CASE Op-Ed in RealClear Markets: Gary Gensler’s Blundering SEC Mirrors Biden’s Incompetence
Touting historically low approval ratings rivaling that of paper cuts and hay fever, one might think Joe Biden and his handlers...
Touting historically low approval ratings rivaling that of paper cuts and hay fever, one might think Joe Biden and his handlers...
December 8, 2023 As new and revolutionary technologies have improved the economy throughout our nation’s history, Washington has often...
Gerard Scimeca – Chairman, CASE July 5, 2021 Imagine trying to make a purchase online from a familiar website,...
Gerard Scimeca – Chairman, CASE November 18th, 2020 There is no denying that all of us are now witnessing a...
Gerard Scimeca – Chairman, CASE January 14, 2020 Before he became the world’s richest man, Jeff Bezos was sailing in...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/
© 2024 · Case for Consumers